Join the Cervical Cancer group to help and get support from people like you.
Cervical Cancer News (Page 2)
Related terms: Cancer, Cervix
Cervical Cancer Screening Lower in Rural Than Urban Health Centers
MONDAY, March 25, 2024 – Up-to-date cervical cancer screening is lower in rural than urban community health centers (CHCs), with the differences mainly due to CHC-level characteristics, according to...
Simple Hysterectomy Not Inferior for Pelvic Recurrence in Cervical Cancer
THURSDAY, Feb. 29, 2024 – For patients with low-risk cervical cancer, simple hysterectomy is not inferior to radical hysterectomy with respect to incidence of pelvic recurrence at three years,...
Which Families Are Less Likely to Get Teens the HPV Vaccine?
TUESDAY, Feb. 27, 2024 – Well-to-do American families are more likely than poorer families to increase their children’s risk of cervical cancer by skipping the human papillomavirus (HPV) vaccine, a n...
Incidence of Cervical Cancer Has Increased in Recent Years
TUESDAY, Jan. 30, 2024 – The incidence and mortality of cervical cancer increased in specific racial/ethnic groups during recent years, according to a study published online Jan. 17 in the...
Cervical Cancer Rates Are on the Rise Among the Poor
FRIDAY, Jan. 26, 2024 – Women in poorer areas of the United States have experienced a dramatic increase in advanced cervical cancer, a new study shows. Late-stage cervical cancer cases and deaths...
FDA Approves Merck’s Keytruda (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for Keytruda in cervical cancer and...
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer
FRIDAY, Jan. 5, 2024 – For patients with metastatic, persistent, or recurrent cervical cancer, adding atezolizumab to a standard bevacizumab plus platinum regimen significantly improves...
White Women Overrepresented in Gynecologic Cancer Trials
TUESDAY, Dec. 12, 2023 – White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open. Wafa Khadraoui, ...
Watch or Remove? Study Finds One Option May Be Better for Abnormal Cervical Lesions
Key Takeaways Cervical lesions are sometimes found on gynecologic exams, and they can later become cancerous A new study finds the longer-term risks of leaving the lesions intact while watching...
Direct-Mail Self-Sampling Increases Uptake of Cervical Cancer Screening
THURSDAY, Nov. 30, 2023 – For individuals who are due or overdue for cervical cancer screening, direct-mail human papillomavirus (HPV) self-sampling increases screening uptake, according to a study...
Active Surveillance Tied to Higher Long-Term Cervical Cancer Risk
THURSDAY, Nov. 30, 2023 – Undergoing active surveillance for cervical intraepithelial neoplasia grade 2 (CIN2) is associated with higher long-term risk for cervical cancer compared with that seen...
Best Way to Prevent Cervical Cancers: Immunize Boys Against HPV, Too
THURSDAY, Nov. 9, 2023 – The best way to prevent cervical cancer in women is to give HPV vaccines to both boys and girls, a new study argues. That way, herd immunity could help eradicate the...
Cervical Cancer: What It Is, Symptoms and Treatment
Cervical cancer is a diagnosis no woman wants to receive, and navigating the disease can be challenging. A type of cancer that starts in the cells of the cervix, this cancer usually develops slowly....
FDA Approves Vegzelma (bevacizumab-adcd), a Biosimilar to Avastin
Vegzelma is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA Vegzelma offers U.S. patients living with multiple types of cancer a new, safe, and effective treatment option ...
FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin
BRIDGEWATER, N.J.--(BUSINESS WIRE) April 13, 2022 --Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...